Target Audience:

This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with congenital sucrase-isomaltase deficiency (CSID) and irritable bowel syndrome (IBS).

Learning Objectives:

After completing this activity, the participant should be better able to:

  • Describe the prevalence of CSID in patients with common GI disorders
  • Incorporate current diagnostic strategies to differentiate CSID from other causes of persistent diarrhea seen in clinical practice, particularly among patients with suspected IBS
  • Summarize the benefits and limitations of current treatment strategies for CSID

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and the Gi Health Foundation. Medical Education Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Credit

Medical Education Resources designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

Americans With Disabilities Act

The event staff will be glad to assist you with any special needs (e.g., physical or dietary). Please contact us prior to the event at 973-833-9609.

There is no fee for this educational activity.

This activity is jointly provided by MER and the Gi Health Foundation.

This activity is jointly provided by Medical Education Resources and the GI Health Foundation, Inc.

This program is supported by an educational grant from QOL Medical LLC.

Saturday, June 3, 2023

12:45 PM - 1:45 PM PT

Hyatt Regency Huntington Beach

21500 Pacific Coast Highway
Huntington Beach, California



12:45 - 12:50 PM


12:50 - 1:00 PM

Overview of Carbohydrate Digestion and Absorption

1:00 - 1:10 PM

Understanding Disaccharidase Deficiency

1:10 - 1:25 PM

Diagnostic Testing in CSID

1:25 - 1:35 PM

Managing CSID

1:35 - 1:45 PM

Q&A Closing Remarks

Amy Kassebaum-Ladewski, PA

Amy Kassebaum-Ladewski is a physician assistant in the Department of Digestive Health at Northwestern Memorial Hospital in Chicago, Illinois. She specializes in functional bowel and neurogastromotility disorders, in addition to managing general GI patients. With a background as a registered dietitian, she prioritizes nutrition therapy with her GI patients. She currently serves as the vice president of GHAPP, with a mission to educate and advance the careers of GI APPs.

Speaker Disclosures

Consultant: Alfasigma USA, Inc., Salix Pharmaceuticals

Speakers' Bureau: Takeda Pharmaceuticals U.S.A., Inc., Salix Pharmaceuticals

Kimberly Orleck, PA

Kimberly Orleck is a physician assistant with Atlanta Gastroenterol-ogy Associates, part of United Digestive. She treats all types of GI disorders but has a special interest in IBD and functional bowel dis-orders. In addition to her clinical practice, she is the lead APP for their 55 APPs. She is also on ACG's APP committee, serves as the education chair for GHAPP, and holds a part-time faculty position in Emory's PA program.

Speaker Disclosures

Consultant: AbbVie Inc., Janssen Biotech, Inc., Phathom Pharmaceuticals, Salix Pharmaceuticals
Speakers' Bureau: AbbVie Inc., Janssen Biotech, Inc.